Navigation Links
Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
Date:3/18/2008

SAN FRANCISCO, March 18 /PRNewswire-USNewswire/ -- W. Scott Harkonen, M.D., the former CEO of InterMune Inc., was indicted on wire fraud and felony Food, Drug and Cosmetic Act charges for his role in the creation and dissemination of false and misleading information about the efficacy of InterMune's drug Actimmune (Interferon gamma-1b) as a treatment for idiopathic pulmonary fibrosis (IPF), the Justice Department announced today.

The indictment alleges that Harkonen, a medical doctor, was the chief executive officer of InterMune from February 1998 through June 30, 2003, and a member of InterMune's board of directors from February 1998 through September 2003. Under Harkonen's direction, InterMune marketed and sold Actimmune to treat IPF, a fatal disease, despite the fact that the drug was not approved by the Food and Drug Administration (FDA) as a safe and effective treatment.

According to the indictment, Harkonen promoted and caused the promotion by InterMune of Actimmune as a safe and effective treatment for IPF, despite the lack of FDA approval, in order to sell more Actimmune and to generate revenues and profits from sales of the pharmaceutical for InterMune. The cost of Actimmune for one IPF patient for one year was approximately $50,000 and the vast majority of the company's sales of Actimmune were for the unapproved, off-label use of treating IPF.

The indictment further states that Harkonen devised a scheme to induce doctors to prescribe, and patients to take, Actimmune to treat IPF. As part of that scheme to defraud, on Aug. 28, 2002, InterMune issued a press release publicly announcing the results of a clinical trial of Actimmune for the treatment of IPF. Although the clinical trial in fact failed, Harkonen caused the issuance and distribution of a false and misleading press release to portray that the results of the trial established that Actimmune helped IPF patients live longer. Specifically, the press release's headline
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post
2. Former Federal Reserve Chairman Paul Volcker To Join Board of Directors of Still River Systems
3. Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice
4. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
5. Lilly and Partners In Health, Brigham and Womens Hospital Team Up to Fight MDR-TB in Former Soviet Republics
6. Former Biolase CEO & EVP Launch Technology4Medicine
7. Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements
8. OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management
9. Local VA Performers Hold February 15 Benefit to Reduce $10,000 in Medical Bills for Former VCU Student Kellie Brown
10. Herley Industries Announces the Passing of Its Former President
11. Former Navy Surgeon General Is Among Three New Accomplished TriWest Advisory Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... 28, 2014 Miami's Plastic Surgery of ... Practice founder Dr. Jeffrey Epstein is excited ... a groundbreaking WordPress platform, the site is uniquely designed ... Currently, up to 75% of all prospective rhinoplasty patients ... people are logging on with smartphones, tablets, and laptops, ...
(Date:11/28/2014)... 2014 Secura Consultants, based in ... marketing organizations in the country focused on delivering ... marketplace. Secura Consultants is proud to offer complimentary ... Group, a leading global financial company. , Many ... the ownership interest comes the need for business ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this ... as gastroesophageal reflux disease (GERD) -- a few steps may ... nose and throat specialist at Lenox Hill Hospital in New ... on Thanksgiving: Pace yourself. Rather than ... throughout the day. It,s also a good idea to have ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 ... prediabetes testing and treatment, helped employees learn their ... on-site diabetes blood screening at a local school ... Diabetes @ Work initiative. , As the ... Work program , PreDiabetes Centers is co-hosting diabetes-prevention ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... MECHANICSBURG, Pa., Nov. 12 Select Medical Corporation,("Select") ... Inc. ("CORA"),have mutually agreed to terminate the Agreement ... on October 1, 2007, pursuant to which Select ... Medical Corporation is a leading operator of specialty ...
... biologists at Jeffersons Kimmel Cancer Center in Philadelphia ... some potentially dangerous autoinflammatory diseases. In doing so, ... of the disease process, but have also identified ... arthritis to cancer. , Reporting in the journal ...
... 13, 8:00 EST -, SOUTH SAN FRANCISCO, ... a biopharmaceutical company, and Raven,biotechnologies, inc., a privately ... therapeutics (MAbs) for treating cancer, announced,today that their ... merger agreement. The merger is expected to create ...
... 12 Northwestern University,announced today that it ... study for women with locally recurrent or ... the efficacy of Nexavar(R),(sorafenib) tablets in combination ... cancer. Nexavar, an oral multi kinase inhibitor ...
... Letters to HHS Office of Inspector General and,Congressman ... Today, the American,Association for Homecare vigorously disputed the ... a basis for setting reimbursement rates for,power wheelchairs ... The Association outlined its concerns in letters sent ...
... found , MONDAY, Nov. 12 (HealthDay News) -- Correcting ... of life, it may lower risks for depression, U.S. ... Alabama at Birmingham studied 78 nursing home residents, 55 ... an eye exam and 64 residents who received eyeglasses ...
Cached Medicine News:Health News:Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 3Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 4Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 5Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 6Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 2Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 3Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 2Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 3Health News: Eyeglasses Upgrade Helps Elderly Battle Depression 2
(Date:11/28/2014)... , Nov. 28, 2014 Aratana Therapeutics, ... focused on the licensing or acquisition, development and commercialization ... companion animals, today announced that it will present at ... to be held December 2-3, 2014, at the New ... . Steven St. Peter , M.D., ...
(Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Hovione Files its First Investigational New Drug Application With the FDA 2
... in a row, A dvertising ... www.eveo.com ) as the #1 Independent Digital Healthcare Agency in the ... d A ge rankings, ... (Photo:   http://photos.prnewswire.com/prnh/20110516/SF03150 ) (Logo:   http://photos.prnewswire.com/prnh/20100630/SF29260LOGO-a ...
... enhanced the capability of its GlideScope® Cobalt AVL video ... designed for small children.  The new Stat is a ... patents weighing from 10 to 28 kilograms, extending the ... kilograms) through patients weighing up to 28 kilograms. ...
Cached Medicine Technology:Eveo Ranked #1 Independent Digital Healthcare Agency in U.S. 2nd Year in a Row 2Verathon Extends Range of GlideScope Video Laryngoscope With New Single Use - GVL 2.5 Stat for Small Children 2
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: